Navidea Biopharmaceuticals Current Ratio 2010-2023 | NAVB
Navidea Biopharmaceuticals current ratio from 2010 to 2023. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Navidea Biopharmaceuticals Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2023-09-30 | $0.01B | $0.01B | 0.56 |
| 2023-06-30 | $0.01B | $0.01B | 0.84 |
| 2023-03-31 | $0.00B | $0.01B | 0.13 |
| 2022-12-31 | $0.00B | $0.01B | 0.32 |
| 2022-09-30 | $0.01B | $0.01B | 0.61 |
| 2022-06-30 | $0.00B | $0.01B | 0.22 |
| 2022-03-31 | $0.00B | $0.01B | 0.47 |
| 2021-12-31 | $0.01B | $0.01B | 1.02 |
| 2021-09-30 | $0.01B | $0.00B | 1.87 |
| 2021-06-30 | $0.01B | $0.00B | 2.50 |
| 2021-03-31 | $0.01B | $0.00B | 2.12 |
| 2020-12-31 | $0.01B | $0.01B | 1.39 |
| 2020-09-30 | $0.01B | $0.00B | 1.19 |
| 2020-06-30 | $0.01B | $0.00B | 1.46 |
| 2020-03-31 | $0.00B | $0.00B | 0.79 |
| 2019-12-31 | $0.00B | $0.00B | 0.76 |
| 2019-09-30 | $0.00B | $0.00B | 0.90 |
| 2019-06-30 | $0.01B | $0.00B | 1.69 |
| 2019-03-31 | $0.00B | $0.00B | 0.95 |
| 2018-12-31 | $0.01B | $0.00B | 1.66 |
| 2018-09-30 | $0.01B | $0.01B | 1.22 |
| 2018-06-30 | $0.01B | $0.01B | 1.43 |
| 2018-03-31 | $0.02B | $0.01B | 1.35 |
| 2017-12-31 | $0.01B | $0.01B | 1.71 |
| 2017-09-30 | $0.02B | $0.01B | 2.58 |
| 2017-06-30 | $0.02B | $0.01B | 2.13 |
| 2017-03-31 | $0.02B | $0.01B | 2.18 |
| 2016-12-31 | $0.01B | $0.07B | 0.16 |
| 2016-09-30 | $0.01B | $0.06B | 0.15 |
| 2016-06-30 | $0.01B | $0.06B | 0.11 |
| 2016-03-31 | $0.01B | $0.06B | 0.18 |
| 2015-12-31 | $0.01B | $0.01B | 2.03 |
| 2015-09-30 | $0.02B | $0.01B | 2.40 |
| 2015-06-30 | $0.02B | $0.01B | 3.50 |
| 2015-03-31 | $0.01B | $0.01B | 0.62 |
| 2014-12-31 | $0.01B | $0.01B | 0.95 |
| 2014-09-30 | $0.01B | $0.01B | 1.68 |
| 2014-06-30 | $0.02B | $0.01B | 3.34 |
| 2014-03-31 | $0.03B | $0.01B | 5.42 |
| 2013-12-31 | $0.04B | $0.01B | 3.31 |
| 2013-09-30 | $0.05B | $0.01B | 7.55 |
| 2013-06-30 | $0.03B | $0.01B | 6.09 |
| 2013-03-31 | $0.01B | $0.01B | 2.07 |
| 2012-12-31 | $0.01B | $0.01B | 1.72 |
| 2012-09-30 | $0.01B | $0.01B | 1.74 |
| 2012-06-30 | $0.02B | $0.01B | 3.34 |
| 2012-03-31 | $0.02B | $0.01B | 4.78 |
| 2011-12-31 | $0.03B | $0.00B | 8.97 |
| 2011-09-30 | $0.03B | $0.00B | 7.87 |
| 2011-06-30 | $0.01B | $0.01B | 2.28 |
| 2011-03-31 | $0.01B | $0.00B | 2.99 |
| 2010-12-31 | $0.01B | $0.00B | 2.59 |
| 2010-09-30 | $0.01B | $0.00B | 1.64 |
| 2010-06-30 | $0.01B | $0.00B | 2.41 |
| 2010-03-31 | $0.01B | $0.00B | 2.54 |
| 2009-12-31 | $0.01B | $0.00B | 3.59 |
| 2009-09-30 | $0.01B | $0.00B | 3.55 |
| 2009-06-30 | $0.01B | $0.00B | 2.79 |
| 2009-03-31 | $0.01B | $0.00B | 3.02 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.000B | $0.000B |
| Navidea Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agents for diseases such as cancer and Alzheimer. The Company's radiopharmaceutical development programs include: Lymphoseek(R), AZD4694 and RIGScan(TM). Navidea Biopharmaceuticals, Inc., formerly Neoprobe Corporation, is headquartered in Dublin, Ohio. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $184.456B | 22.32 |
| Intuitive Surgical (ISRG) | United States | $170.011B | 70.47 |
| IDEXX Laboratories (IDXX) | United States | $51.341B | 53.43 |
| Edwards Lifesciences (EW) | United States | $47.714B | 31.62 |
| Alcon (ALC) | Switzerland | $40.175B | 26.97 |
| IQVIA Holdings (IQV) | United States | $31.919B | 18.04 |
| DexCom (DXCM) | United States | $29.851B | 44.78 |
| Mettler-Toledo (MTD) | United States | $26.465B | 31.41 |
| STERIS (STE) | Ireland | $24.483B | 26.06 |
| Waters (WAT) | United States | $17.627B | 24.21 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.949B | 0.00 |
| Hologic (HOLX) | United States | $14.820B | 16.06 |
| Penumbra (PEN) | United States | $10.374B | 75.78 |
| Globus Medical (GMED) | United States | $8.357B | 19.28 |
| Sysmex ADR (SSMXY) | Japan | $8.133B | 25.84 |
| Masimo (MASI) | United States | $7.782B | 26.19 |
| Teleflex (TFX) | United States | $5.623B | 9.08 |
| Glaukos (GKOS) | United States | $5.379B | 0.00 |
| TransMedics (TMDX) | United States | $3.927B | 59.68 |
| Integer Holdings (ITGR) | United States | $3.800B | 18.96 |
| LivaNova (LIVN) | United Kingdom | $3.090B | 17.68 |
| Veracyte (VCYT) | United States | $2.287B | 31.60 |
| PROCEPT BioRobotics (PRCT) | United States | $2.254B | 0.00 |
| Artivion (AORT) | United States | $2.078B | 104.83 |
| Nihon Kohden (NHNKY) | Japan | $1.950B | 23.28 |
| Elekta AB (EKTAY) | Sweden | $1.864B | 17.43 |
| Integra LifeSciences Holdings (IART) | United States | $1.150B | 6.59 |
| Pulse Biosciences (PLSE) | United States | $1.138B | 0.00 |
| OPKO Health (OPK) | United States | $1.103B | 0.00 |
| IRadimed (IRMD) | United States | $0.925B | 44.87 |
| Tandem Diabetes Care (TNDM) | United States | $0.827B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.797B | 0.00 |
| AxoGen (AXGN) | United States | $0.746B | 0.00 |
| SiBone (SIBN) | United States | $0.708B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.573B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.555B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.470B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.456B | 3.66 |
| AngioDynamics (ANGO) | United States | $0.398B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.396B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.389B | 92.67 |
| Mesa Laboratories (MLAB) | United States | $0.381B | 9.70 |
| RxSight (RXST) | United States | $0.348B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.302B | 0.00 |
| NeuroPace (NPCE) | United States | $0.297B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.290B | 20.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.282B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.280B | 0.00 |
| 908 Devices (MASS) | United States | $0.228B | 0.00 |
| Neuronetics (STIM) | United States | $0.224B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.223B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.222B | 0.00 |
| Inogen (INGN) | United States | $0.216B | 0.00 |
| CVRx (CVRX) | United States | $0.198B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.177B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.166B | 0.00 |
| LENSAR (LNSR) | United States | $0.150B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.128B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.117B | 0.00 |
| InspireMD (NSPR) | United States | $0.103B | 0.00 |
| Hyperfine (HYPR) | United States | $0.099B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.091B | 0.00 | |
| QT Imaging Holdings (QTIH) | United States | $0.072B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.057B | 0.00 |
| Spectral AI (MDAI) | United States | $0.055B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.054B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.044B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.039B | 0.00 |
| Precision Optics (POCI) | United States | $0.038B | 0.00 |
| Envoy Medical (COCH) | United States | $0.025B | 0.00 |
| DarioHealth (DRIO) | United States | $0.024B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.022B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.017B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
| Tenon Medical (TNON) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.011B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.007B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 13.48 |